# Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19

> **NCT04900155** · NA · UNKNOWN · sponsor: **Penza State University** · enrollment: 45 (actual)

## Conditions studied

- STEMI
- Covid19
- NSTEMI

## Interventions

- **DRUG:** Atorvastatin 80mg
- **DRUG:** Atorvastatin-Ezetimibe

## Key facts

- **NCT ID:** NCT04900155
- **Lead sponsor:** Penza State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-20
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04900155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04900155, "Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04900155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*